Metabolism, biochemical actions, and chemical synthesis of anticancer nucleosides, nucleotides, and base analogs

J Shelton, X Lu, JA Hollenbaugh, JH Cho… - Chemical …, 2016 - ACS Publications
Nucleoside, nucleotide, and base analogs have been in the clinic for decades to treat both
viral pathogens and neoplasms. More than 20% of patients on anticancer chemotherapy …

Glucose transporters in cancer metabolism

K Adekola, ST Rosen… - Current opinion in …, 2012 - journals.lww.com
Tumor cells exhibit elevated levels of glucose uptake, a phenomenon that has been
capitalized upon for the prognostic and diagnostic imaging of a wide range of cancers using …

Autophagy is a therapeutic target in anticancer drug resistance

S Chen, SK Rehman, W Zhang, A Wen, L Yao… - … et Biophysica Acta (BBA …, 2010 - Elsevier
Autophagy is a type of cellular catabolic degradation response to nutrient starvation or
metabolic stress. The main function of autophagy is to maintain intracellular metabolic …

Autophagy as a therapeutic target in cancer

N Chen, V Karantza - Cancer biology & therapy, 2011 - Taylor & Francis
Autophagy is a self-catabolic process that maintains intracellular homeostasis and prolongs
cell survival under stress via lysosomal degradation of cytoplasmic constituents and …

Calcium homeostasis and ER stress in control of autophagy in cancer cells

E Kania, B Pająk, A Orzechowski - BioMed research …, 2015 - Wiley Online Library
Autophagy is a basic catabolic process, serving as an internal engine during responses to
various cellular stresses. As regards cancer, autophagy may play a tumor suppressive role …

[HTML][HTML] Autophagy and tumorigenesis

N Chen, J Debnath - FEBS letters, 2010 - Elsevier
Autophagy, or cellular self-digestion, is activated in cancer cells in response to multiple
stresses and has been demonstrated to promote tumor cell survival and drug resistance …

Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy

SK McBrayer, JC Cheng, S Singhal… - Blood, The Journal …, 2012 - ashpublications.org
Multiple myeloma is one of numerous malignancies characterized by increased glucose
consumption, a phenomenon with significant prognostic implications in this disease. Few …

Dichloroacetate inhibits aerobic glycolysis in multiple myeloma cells and increases sensitivity to bortezomib

WY Sanchez, SL McGee, T Connor, B Mottram… - British journal of …, 2013 - nature.com
Background: Dichloroacetate (DCA), through the inhibition of aerobic glycolysis (the
'Warburg effect') and promotion of pyruvate oxidation, induces growth reduction in many …

Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis

A Van der Vreken, I Oudaert, G Ates… - The Journal of …, 2023 - Wiley Online Library
Multiple myeloma (MM) remains an incurable haematological malignancy despite
substantial advances in therapy. Hypoxic bone marrow induces metabolic rewiring in MM …

Autophagy and apoptosis: current challenges of treatment and drug resistance in multiple myeloma

OS Al-Odat, DA Guirguis, NK Schmalbach… - International Journal of …, 2022 - mdpi.com
Over the past two decades, the natural history of multiple myeloma (MM) has evolved
dramatically, owing primarily to novel agents targeting MM in the bone marrow …